Effects of sleep disturbance on neuropsychological functioning in patients with pediatric brain tumor
Jenna A Chiang1,2, Paulina T Feghali1,2, Anita Saavedra1,2
1Cancer and Blood Disease Institute, Children's Hospital Los Angeles (CHLA), Los Angeles, CA, USA.
Insights
Pediatric brain tumor patients often have sleep problems, including shorter sleep duration and daytime napping. Poor sleep in these children is linked to worse adaptive and executive functioning, impacting their long-term outcomes.
Area of Science:
- Neuroscience
- Pediatric Oncology
- Sleep Medicine
Background:
- Sleep disturbances are common in children with pediatric brain tumors (PBT).
- Existing research on sleep and cognition in typically developing children is extensive, but limited in PBT populations.
- PBT patients face unique challenges that may exacerbate sleep issues.
Purpose of the Study:
- To investigate the impact of sleep factors on patient-reported outcome (PRO) measures in children with PBT.
- To assess the relationship between sleep patterns and adaptive/executive functioning in this population.
Main Methods:
- Retrospective analysis of 133 PBT patients (ages 5-23).
- Neuropsychological evaluation including adaptive and executive functioning assessments.
- Collection of subjective sleep concerns, nocturnal sleep duration, and daytime napping behavior, compared to age-based guidelines.
Main Results:
- Nearly 30% of PBT patients reported sleep concerns.
- The study sample exhibited reduced nocturnal sleep duration (approx. 1 hour less than recommended).
- Almost half of patients reported regular daytime napping, deviating from typical monophasic sleep patterns.
- Inadequate sleep was significantly associated with decreased adaptive functioning (p=.022) and increased executive dysfunction symptoms (p=.003).
Conclusions:
- Pediatric brain tumor patients frequently display abnormal sleep patterns.
- These sleep abnormalities correlate with poorer long-term patient-reported outcomes.
- Further research is needed to understand the interplay of diagnostic, treatment, and demographic factors to guide interventions for sleep issues in PBT.
Purpose:
While the effects of sleep on cognition in typically developing children are well established, there is a paucity of research in patients with pediatric brain tumor (PBT), despite their increased risk for sleep-related disturbances. The aim of this retrospective study was to examine the impact of sleep factors on patient-reported outcome (PRO) measures, including adaptive and executive functioning within this population.
Methods:
133 patients with PBT (52% male) ages 5-23 (x̄ = 12.8 years; SD = 4.5 years) underwent neuropsychological evaluation, including assessment of adaptive and executive functioning. Subjective sleep concerns, nocturnal sleep duration, and daytime sleep behavior were also collected and compared to age-based guidelines.
Results:
Nearly 30% of patients endorsed subjective sleep concerns, while the sample as a whole reported reduced nocturnal sleep duration (approximately one hour below age-based recommendations). Despite the expectation for monophasic sleep by age five, nearly half of the sample reported consistent daytime napping. Inadequate sleep predicted decreased adaptive functioning, F(1, 56) = 4.23, p = .022 (R2 = .07), as well as increased symptoms of executive dysfunction, F(1, 108) = 3.51, p = .003 (R2 = .03).
Conclusion:
Patients with PBT demonstrate several aspects of abnormal sleep, which are associated with poorer long-term PROs. Further exploration of diagnostic, treatment-related, and demographic variables will be needed to better understand these relationships among patients with PBT in order to inform appropriate interventions.
Related Concept Videos
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Nightmares and Night Terrors
Nightmares...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Pharmacokinetics in Pediatric Patients: Drug Metabolism


